StanleyLeonHazenMD

Endocrinology

Professor, Molecular Medicine, Case Western Reserve University School of Medicine. Preventative Cardiology

Dr. Hazen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1996
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1992 - 1994
Washington University in St. Louis School of MedicineClass of 1992

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Elected Member The American Society for Clinical Investigation, 2003
Fellow (FACC) American College of Cardiology

PubMed

Reply to Guyton, J. R. & Boden, W. E.; Schreiber, S. et al.
W H Wilson Tang, Joseph A DiDonato, Hooman Allayee, Stanley L Hazen
Nature Medicine. 2024-09-01
Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptors.
Prasenjit Prasad Saha, Valentin Gogonea, Wendy Sweet, Maradumane L Mohan, Khuraijam Dhanachandra Singh
Nature Communications. 2024-08-06
Publisher Correction: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk.
Marc Ferrell, Zeneng Wang, James T Anderson, Xinmin S Li, Marco Witkowski
Nature Medicine. 2024-06-01

Journal Articles

Dietary Metabolism, the Gut Microbiome, and Heart Failure
Stanley L Hazen, Daniel Y Li, Nature
Development of a Gut Microbe–Targeted Nonlethal Therapeutic to Inhibit Thrombosis Potential
Stanley Hazen, MD, Nature
Elevated Levels of Plasma Symmetric Dimethylarginine and Increased Arginase Activity as Potential Indicators of Cardiovascular Comorbidity in Rheumatoid Arthritis
Stanley Hazen, MD, BioMed Central
Myeloperoxidase Aggravates Pulmonary Arterial Hypertension by Activation of Vascular Rho-Kinase
Stanley Hazen, MD, The Journal of Clinical Investigation
Join now to see all

Long Covid: The Search for Answers Inches ForwardDecember 6th, 2024
Covid Can Raise the Risk of Heart Problems for YearsNovember 22nd, 2024
New Research Suggests Contracting This Disease Will Double Your Risk of a Heart AttackOctober 31st, 2024
Join now to see all